Thomas M. Ludden
About
In The Last Decade
Thomas M. Ludden
156 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 177
- Pediatrics, Perinatology and Child Health 766
- Pharmacology 687
- Pharmacology 612
- Molecular Biology 505
- Oncology 492
Countries citing papers authored by Thomas M. Ludden
This map shows the geographic impact of Thomas M. Ludden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Ludden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Ludden more than expected).
Fields of papers citing papers by Thomas M. Ludden
This network shows the impact of papers produced by Thomas M. Ludden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Ludden. The network helps show where Thomas M. Ludden may publish in the future.
Co-authorship network of co-authors of Thomas M. Ludden
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Ludden. A scholar is included among the top collaborators of Thomas M. Ludden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Ludden. Thomas M. Ludden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 19 | |
| 4 | 39 | |
| 5 | 17 | |
| 6 | 3 | |
| 7 | 49 | |
| 8 | 10 | |
| 9 | 12 | |
| 10 | Disposition of phenytoin in critically ill trauma patients. | 16 |
| 11 | 4 | |
| 12 | Hydralazine elimination is saturable after oral but not intravenous administration | 2 |
| 13 | Phenytoin dosage predictions using bayesian feedback | 1 |
| 14 | Determination of acetylator phenotype in hypertensive patients with renal impairment | 5 |
| 15 | A-1. Dose-independent hydralazine pharmacokinetics after intravenous administration to hypertensive patients | 2 |
| 16 | B-6. Pharmacokinetics of a new β-lactam antibiotic, moxalactam | 1 |
| 17 | Development of a loading regimen for aspirin | 1 |
| 18 | Hydralazine disposition following a single oral dose in human volunteers | 1 |
| 19 | Relationships between plasma hydralazine (H) concentrations and hypotensive response in patients | 1 |
| 20 | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.